Skip to content

Medical-device intelligence

QXW: Cryoablation Device For Local Treatment Of Low-Risk Breast Cancer

FDA product code QXW: Cryoablation Device For Local Treatment Of Low-Risk Breast Cancer. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QXW
FDA device name
Cryoablation Device For Local Treatment Of Low-Risk Breast Cancer
Device class
2
Regulation number
878.4355
Medical specialty
General, Plastic Surgery
Review panel
SU

FDA definition

A cryoablation device for local treatment of low-risk breast cancer is a prescription device that uses cold temperatures to destroy a breast tumor and its surrounding tissue. The device is intended as a local treatment and may be used with adjuvant therapies (e.g., endocrine therapy, radiation therapy) to reduce the risk of local disease progression. The device is intended for use in patients with a well-defined solid tumor (e.g., invasive ductal carcinoma) and with low risk of recurrence and metastasis, as determined by clinical risk factors consistent with the indications for use. The device is not intended to treat breast cancers with high risk of local recurrence (e.g., lobular carcinoma), patients with aggressive forms of breast cancer (e.g., breast cancers with inflammatory features), or patients in whom targeted systemic therapy is indicated.
Explore general, plastic surgery records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

0 clearance records and 0 recall records in the covered releases, across 0 source company names and 0 product codes. No dated record history is available in this scope.

No records in these releases does not establish that a device has never been marketed, cleared, or recalled. Classification entries can exist without a matching clearance or recall in the covered datasets. Consult the original classification and the appropriate FDA pathway.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

0 matching records
No matching records in the current covered data. This does not establish that a product is unmarketed or free of recalls. Check the source coverage and try broader criteria.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗